Main Session
Sep 29
SS 15 - Radiation Biology 2: Novel Immunotherapeutics & Biomarker Discovery

188 - RC48-ADC Combined with Radiotherapy and Immunotherapy as Salvage Therapy for Advanced Solid Tumors with HER2 Expression: A Multicenter, Phase II Trial

08:00am - 08:10am PT
Room 22/23

Presenter(s)

Meiling Xu, MD, PhD, RT - The Second Affiliated Hospital of Soochow University, Suzhou, Jiangsu